| [June 17, 2016] |
 |
Global Diabetic Retinopathy Pipeline Report 2016 - Review of 41 Therapeutics Companies & Drug Profile Activity - Research and Markets
Research and Markets has announced the addition of the "Diabetic
Retinopathy - Pipeline Review, H1 2016" report to their
offering.
This report provides comprehensive information on the therapeutic
development for Diabetic Retinopathy, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with the latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Diabetic
Retinopathy and special features on late-stage and discontinued projects.
The report enhances decision-making capabilities and helps to create
effective counter-strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MoAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Diabetic Retinopathy Overview
-
Therapeutics Development
-
Pipeline Products for Diabetic Retinopathy - Overview
-
Pipeline Products for Diabetic Retinopathy - Comparative Analysis
-
Diabetic Retinopathy - Therapeutics under Development b Companies
-
Diabetic Retinopathy - Therapeutics under Investigation by
Universities/Institutes
-
Diabetic Retinopathy Products Glance
-
Late-Stage Products
-
Clinical-Stage Products
-
Early-Stage Products
-
Diabetic Retinopathy - Products under Development by Companies
-
Diabetic Retinopathy - Products under Investigation by
Universities/Institutes
-
Diabetic Retinopathy - Companies Involved in Therapeutics Development
-
Acucela Inc.
-
Aerie Pharmaceuticals, Inc.
-
Aerpio Therapeutics, Inc.
-
Antisense Therapeutics Limited
-
BCN (News - Alert) Peptides, S.A.
-
Biomar Microbial Technologies
-
Charlesson LLC
-
Coherus BioSciences, Inc.
-
Crinetics Pharmaceuticals, Inc.
-
Diffusion Pharmaceuticals Inc.
-
Dimerix Bioscience Pty. Ltd.
-
Dynamis Therapeutics, Inc.
-
EyeGene, Inc.
-
Foresee Pharmaceuticals, LLC
-
GTx, Inc.
-
Icon Bioscience, Inc.
-
Islet Sciences, Inc.
-
Kodiak Sciences, Inc.
-
Kowa Company, Ltd.
-
LegoChem Biosciences, Inc.
-
Lpath, Inc.
-
M's Science Corporation
-
Mabion SA
-
MingSight Pharmaceuticals
-
OcuCure Therapeutics, Inc.
-
Oculis ehf
-
Ohr Pharmaceutical Inc.
-
PanOptica, Inc.
-
Promedior, Inc.
-
Ribomic Inc.
-
Sirnaomics, Inc.
-
Stelic Institute & Co., Inc.
-
Stemedica Cell Technologies, Inc.
-
Strongbridge Biopharma plc
-
Xbrane Biopharma AB
For more information visit http://www.researchandmarkets.com/research/d9wv59/diabetic.
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160617005780/en/
[ Back To TMCnet.com's Homepage ]
|
